News

'Electronic skin' could improve early breast cancer detection

Scientists are now developing an "electronic skin" that will aid in the detection of breast masses.

Disparities persist in early stage breast cancer treatment

Despite its acceptance as standard of care neary 25 years ago, barriers still exist that preclude patients from receiving breast conserving therapy (BCT), according to research presented at the ASCO 2014 Breast Cancer Symposium.

Adding drugs to standard chemotherapy improves response in triple-negative breast cancer

Adding carboplatin and/or bevacizumab to the standard treatment regimen significantly improved pathologic complete response rates in patients with triple-negative breast cancer, according to a new phase 2 study.

Novel drug safe for patients with leukemia

Results of a phase I clinical trial showed that a new drug targeting mitochondrial function in human cancer cells was safe and showed some efficacy in a heavily pretreated cohort of patients.

ESMO: Herceptin may be best option for HER2 breast cancer treatment

ESMO: Herceptin may be best option for HER2+ breast cancer treatment

Drug should remain standard of care for HER2-positive tumors, according to new research.

No association found between wearing a bra and breast cancer

No association found between wearing a bra and breast cancer

A recent study found no link between bra wearing and increased breast cancer risk among postmenopausal women.

Once-weekly breast radiation regimen improves on current treatment

An experimental regimen of once-weekly breast irradiation after lumpectomy provides more convenience to patients at less expense, and results in better completion rates of prescribed radiation treatment.

ESMO: Combination treatments increase metastatic melanoma survival

ESMO: Combination treatments increase metastatic melanoma survival

Studies show improved progression-free melanoma survival for both cobimetinib combined with vemurafenib, and dabrafenib combined with trametinib.

Novel immunotherapy vaccine decreases recurrence of HER2-positive breast cancer

Novel immunotherapy vaccine decreases recurrence of HER2-positive breast cancer

A new immunotherapy vaccine candidate for breast cancer shows promise, having reduced recurrence rate by more than fifty percent.

Prostate cancer treatment controversy continues as study finds watchful waiting not enough for some men

An active controversy among oncologists concerns watchful waiting versus more active treatment for prostate cancer.

Conference Coverage

Disparities persist in early stage breast cancer treatment

Despite its acceptance as standard of care neary 25 years ago, barriers still exist that preclude patients from receiving breast conserving therapy (BCT), according to research presented at the ASCO 2014 Breast Cancer Symposium.

Once-weekly breast radiation regimen improves on current treatment

An experimental regimen of once-weekly breast irradiation after lumpectomy provides more convenience to patients at less expense, and results in better completion rates of prescribed radiation treatment.

Unique cancer mutations may be targets for effective melanoma immunotherapy

Adoptive T-cell therapy, a type of immunotherapy, appears to recognize unique cancer mutations that stimulate immune responses.

Same-day results increase community use of lung screening service

A new lung screening service for persons at high risk for lung cancer with incorporates a same-day visit by a nurse practitioner after the patient undergoes low-dose CT to discuss test results and recommendations.

Needs-assessment survey identifies knowledge gaps of novel therapeutics for CACS

Although nurses are familiar with palliative care guidelines related to cancer anorexia-cachexia syndrome, a needs-assessment survey revealed they are less familiar with novel therapeutic interventions in development.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs